Cannabis Science Inc (OTC:CBIS)

Cannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. It primarily focuses on developing medications to treat autism, blood pressure, cancer and cancer side effects, HIV, and other illnesses, including general health maintenance. Cannabis Science, Inc. is based in Denver, Colorado.

Web site: http://www.cannabisscience.com

Last updated February 28, 2012


Market Data powered by QuoteMedia. Terms of Use